Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma
Clinical trial NCT04926532 · UNKNOWN
Trial details
- NCT number
- NCT04926532
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2021-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.